Patent ID: 8415152

Claim:
A method of treating asthma, comprising the steps of a) culturing dendritic cells (DC) in the presence of interferon (IFN)-gamma, and at least one TLR2 or TLR6 agonist selected from the group of macrophage activating lipopeptide 2 (MALP-2), S-[2,3-bis(palmitoyloxy)-(2S)-propyl-L-cysteinyl-carboxy-polyethyleneglycol and S-[2,3-bis(palmitoyloxy)-(2R)-propyl-L-cysteinyl-carboxy-polyethyleneglycol, and optionally further ingredients, wherein said DC are transformed into activated DC, and b) separating said activated DC from the resulting culture mixture, and c) administering to a subject in need thereof a therapeutically effective amount of said activated DC.